Retinal Imaging for Eye Diseases

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

Recruiting N/A Interventional Study
Diabetic Retinopathy Retinal Vein Occlusion Hypertension,Essential Retinal Vascular Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
1,050 (estimated)
Sponsor
Johns Hopkins University · Other
Who this trial is looking for

This trial is looking for adults with certain eye diseases and healthy controls. By participating, you will help researchers understand how these conditions progress and respond to treatment through eye imaging tests.

Are You a Good Fit for This Trial?
Rules you out Diabetes MellitusHypertensionHeart diseaseThyroid disease

You may not be able to join if

  • I am a child under 18 years old
  • I am pregnant
  • I have developmental delays
  • I cannot give informed consent
  • I have trouble following study instructions
  • I cannot provide clear images due to motion
  • I have a history of glaucoma
  • I have a history of other serious eye diseases

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Exclusion Criteria: * Both subjects with diseases and controls: * Children (age\<18) * Pregnant females * Developmentally delayed subjects * Subjects unable to provide informed consent * Inability to cooperate with tests and study instructions * Images with motion artifact or signal strength \< 7 *…
Contacts

Amir H Kashani, MD, PhD

410-502-2789

akashan1@jhmi.edu

CONTACT

Ana C Martinez, MPH

410-502-2789

acollaz5@jhmi.edu

CONTACT